Chinese Biotechs Ascend Deal-Making By Partnering Up Claudin 18.2 Agents

 
• By Dexter Jie Yan
  
evolve deal making
Six Chinese biotechs have inked deals with major multinationals on the Claudin 18.2 target so far • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia